Aura Corp (AURA): Market Value

Graphic logo of Aura Bio (AURA)

Aura Biosciences, Inc. (AURA) is a specialized brand that preserves vision through the precise destruction of neoplasms using viral particles. Its high authority among ophthalmic surgeons is driven by the use of unique conjugates for the therapy of ocular tumors. Market capitalization stands at 0.74. The price action, which assists in the baseline asset valuation, complements data regarding bladder treatment patents that create monopoly potential despite the absence of a current commercial advantage.

aurabiosciences.com - AURA Market Capitalization (period 07/04/2022 - 11/18/2026)

Metric breakdowns and analytics for aurabiosciences.com (AURA)

Fundamental company valuation:Aura Corp AURA
Product sample of Aura Biosciences, Inc.

Aura Biosciences, Inc. (AURA) occupies a stable niche in biomedicine thanks to the humanitarian status of its developments. Market capitalization reflects the aggregate value of all shares, measuring current investor confidence in future cash flows. By analyzing the company's market valuation, one can track the immediate market reaction to clinical successes. Low geopolitical risks make this indicator more stable. Long-term consensus requires correlating price action with actual commercialization rates.

Competitors of Aura Biosciences, Inc. (AURA)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|CADL: Market Capitalization|Accuray, Inc. - Market Capitalization|Market Value SELLAS Life Sciences Group|ACTU: Market Capitalization|Market Value citiusonc.com (CTOR)|Market Value tuhurabio.com|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group